Trial Profile
Efficacy of Minodronate with Eldecalcitol (MIN/ELD) and Denosumab after 2-year Teriparatide treatment in osteoporosis in subjects with rheumatoid arthritis.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 02 Jan 2017
Price :
$35
*
At a glance
- Drugs Denosumab (Primary) ; Eldecalcitol (Primary) ; Minodronic acid (Primary)
- Indications Osteoporosis; Rheumatoid arthritis
- Focus Therapeutic Use
- 10 Feb 2016 New trial record